HIV and tuberculosis (TB) treatment programs have always relied on clinical trials to understand whether treatment ...

AS a director of the Philippine Tuberculosis Society, Inc. (PTSI), my advocacy extends beyond treating TB — it must also confront one of the strongest drivers of the disease: smoking in all its forms, ...

Tuberculosis is both curable and preventable, yet each year, it still kills more people than any other infectious disease.

Produced by the National Institute of Allergy and Infectious Diseases (NIAID), this digitally colorized scanning electron microscopic (SEM) image, depicts a grouping of red-colored, rod shaped, ...

Tumor necrosis factor (TNF) is a proinflammatory cytokine that has a key role in the pathogenesis of a variety of autoimmune diseases—including rheumatoid arthritis—and is an important constituent of ...

Dolutegravir-based ART with isoniazid was safe and effective for tuberculosis prevention in ART-naïve HIV patients, leading to rapid viral suppression. The study reported minimal adverse events, with ...

Despite efforts to eliminate the disease, 13 million Americans are living with latent tuberculosis infection, according to the most recent statistics from the National Health and Nutrition Examination ...

Bacille Calmette-Guérin (BCG) revaccination didn't help prevent sustained Mycobacterium tuberculosis infection in initially uninfected adolescents without HIV in a randomized trial from South Africa.

Few illnesses lay bare the inequities of the modern global health system like tuberculosis. In 2021 alone, the disease killed 1.6 million people worldwide, more than any other infectious illness ...

U.S. health officials say they have found a far simpler therapy for people at risk of developing tuberculosis, addressing a key barrier to preventing the spread of the disease. Patients who took a ...

Peru’s fight against tuberculosis demonstrates how global neglect endangers public health. COVID-19 setbacks, poverty, and ...

According to the most recent state data, there were 2,100 TB cases reported in California in 2024, representing only a slight decrease from the 2,110 cases identified in 2023.